Background. The 2013 IDSA prosthetic joint infection (PJI) guidelines identified some research gaps, some of which include what factors may predict PJI outcome. We therefore conducted a retrospective single-center study with the goal of addressing some of these gaps.
Parameter
Value ( The incidence rate of PJI for the study period was 5.4%.. Staph. aureus was the commonest pathogen accounting for 11(65%) JA and 13(40%) of IO cultures. Low virulence organisms [Staph. epidermidis n = 8 (25%) and Corynebacterium spp. n =1 (3%)] were only recovered from IO cultures. Gram-negative bacilli accounted for 5(30%) JA and 7(28%) IO cultures.. JA correlates well with IO cultures using paired sample correlations (t-test); (correlation 0.61, P = 0.027).. 97% of subjects had elevated ESR while 96% had elevated CRP.. Concerning outcome, there was no statistically significant difference between groups based on implant duration (P = 0.98), symptom onset (P = 0.23), pathogen type (P = 0.83), and treatment options (P = 0.39).
Conclusion. (gentamicin, vancomycin, gentamicin+clindamycin [G+C] , gentamicin+vancomycin [G+V]) could be used for the fixation of the new prosthesis and could be effective to treat or prevent superinfection. We aim to determine the microbiological epidemiology in patients experiencing failure following reimplantation to establish, based on the drug susceptibilities, which cement could be the most active.
Methods. Prospective cohort study including all patients with a two-stage exchange in 2013-2015. Microbiological failure was defined by positive culture at the time of reimplantation. Clinical failure was defined by patients with clinical signs of infection requiring a new surgery.
Results. We included 117 patients (median age 70 years). Fourteen patients (12%) experienced a failure: seven patients with microbiological failure (four CoNS, one P. acnes, one corynebacterium, and three Candida albicans); seven patients with a clinical relapse requiring a new surgery (three Enterobacteriaceae, two P. aeruginosa, one streptococcus spp., one CoNS, one P. acnes, one E. faecalis). Considering the use of a vancomycin-loaded cement, this antibiotic was inactive on Candida (n = 3) and Gramnegative isolates (n = 5). Considering the use of gentamicin, this antibiotic was inactive on Candida (n = 3) and five bacterial isolates. These five letter isolates were also not susceptible to Clindamycin. Considering the use of G+V, this combination was inactive on Candida (n = 3) and only one bacterial isolate (a gentamicin-resistant K. pneumonia). Consequently, the vancomycin-, gentamicin-and G+C-loaded cements may effectively treat or prevent 42.9% of superinfections, only. Conversely, the G+V-loaded cement may effectively treat or prevent 71.4% of them.
Conclusion. Considering the commercially available antibiotic loaded: none of the Candida albicans superinfection could be locally treated, and the G+V-loaded cement could treat or prevent most bacterial superinfections. 
